RxDoctor Payments Data

Jodi Gerdes, MD

Vascular Surgery · Saint Paul, MNNPI 1033313127

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 81.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $685 and has fallen 74.1% since, to $177 in 2024. That places this record below the midpoint for vascular surgery clinicians in MN, where the typical reported total is $3,317.

$2,021in general payments, 2019–2025

Across 31 payments — averaging $65.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Silk Road Medical, Inc.$226
  • W. L. Gore & Associates, Inc.$83
  • Boston Scientific$27
  • Bard Peripheral Vascular, Inc.$20
  • Getinge USA Sales, LLC$12

What the payments were for

  • Food & beverage$1,92295%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,021 in reported general payments places this provider in the 35th percentile of 84 vascular surgery providers in Minnesota.

See all vascular surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$54,990
Medicare patients
337
Services billed
618

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban18$15,889
ClopidogrelClopidogrel Bisulfate61$1,052
Atorvastatin Calcium34$422

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →